Klaricid/Klaricid OD

Klaricid/Klaricid OD Indications/Uses

clarithromycin

Manufacturer:

Abbott

Distributor:

Abbott
Full Prescribing Info
Indications/Uses
Klaricid: Clarithromycin is indicated for treatment of infections due to susceptible organisms in adults and children 12 years and older. Such infections include: Lower respiratory tract infections (e.g., bronchitis, pneumonia) (see Pharmacology: Pharmacodynamics under Actions and Precautions).
Upper respiratory tract infections (e.g., pharyngitis, sinusitis).
Skin and soft tissue infections (e.g., folliculitis, cellulitis, erysipelas) (see Pharmacology: Pharmacodynamics under Actions and Precautions).
Disseminated or localized mycobacterial infections due to Mycobacterium avium or Mycobacterium intracellulare. Localized infections due to Mycobacterium chelonae, Mycobacterium fortuitum, or Mycobacterium kansasii.
Clarithromycin is indicated for the prevention of disseminated Mycobacterium avium complex infection in HIV-infected patients with CD4 lymphocyte counts less than or equal to 100/mm3.
Clarithromycin in the presence of acid suppression is also indicated for the eradication of H. pylori resulting in decreased recurrence of duodenal ulcer (see Pharmacology: Pharmacodynamics under Actions).
Treatment of odontogenic infections.
Consideration should be given to national official guidance on the appropriate use of antibacterial agents.
Klaricid OD: Clarithromycin is indicated for treatment of infections due to susceptible organisms in adults and children 12 years and older. Such infections include: Lower respiratory tract infections (e.g., bronchitis, pneumonia) (see Pharmacology: Pharmacodynamics under Actions and Precautions).
Upper respiratory tract infections (e.g., pharyngitis, sinusitis).
Skin and soft tissue infections (e.g., folliculitis, cellulitis, erysipelas) (see Pharmacology: Pharmacodynamics under Actions and Precautions).
Treatment of odontogenic infections.
Consideration should be given to national official guidance on the appropriate use of antibacterial agents.
Klaricid Pediatric: Clarithromycin is indicated for treatment of infections due to susceptible organisms in children 6 months to 12 years. Such infections include: Lower respiratory tract infections (e.g., bronchitis, pneumonia) (see Pharmacology: Pharmacodynamics under Actions and Precautions).
Upper respiratory tract infections (e.g., pharyngitis, sinusitis).
Skin and soft tissue infections (e.g., folliculitis, cellulitis, erysipelas) (see Pharmacology: Pharmacodynamics under Actions and Precautions).
Disseminated or localized mycobacterial infections due to Mycobacterium avium or Mycobacterium intracellulare. Localized infections due to Mycobacterium chelonae, Mycobacterium fortuitum, or Mycobacterium kansasii.
Acute otitis media.
Consideration should be given to national official guidance on the appropriate use of antibacterial agents.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in